Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis

J. D. McGarry, D. W. Foster

Research output: Contribution to journalArticle

24 Scopus citations

Abstract

The ability of (+) decanoylcarnitine to inhibit ketogenesis in perfused livers from severely ketotic alloxan diabetic rats and to cause the rapid reversal of ketoacidosis in intact animals was shown not to be the result of a detergent action of this compound, since no such effects were seen when similar experiments were carried out with (-) decanoylcarnitine. Comparison of the hexanoyl, octanoyl and decanoyl esters of (+) carnitine for their antiketogenic capacity in perfused livers from alloxan diabetic rats revealed that the 8 and 10 carbon homologues were equally effective, with the 6 carbon species having less inhibitory properties. When tested in vivo, both in the presence and absence of insulin, the 8 carbon species exhibited the greatest hypoketonemic potential. Further studies with (+) octanoylcarnitine showed that its potent effects in the rat are completely reversible; it is not metabolized in this animal species and is rapidly excreted by the kidneys; it has a far lower hemolytic capacity than (+) decanoylcarnitine; and it is capable of reversing severe ketoacidosis when administered orally, although the doses required using this procedure are much greater than those needed when the agent is given intravenously. It is concluded that (+) acylcarnitines are useful tools for studies of metabolic regulation both in vitro and in vivo. In this regard the compound of choice would seem to be (+) octanoylcarnitine.

Original languageEnglish (US)
Pages (from-to)485-493
Number of pages9
JournalDiabetes
Volume23
Issue number6
DOIs
StatePublished - Jan 1 1974

ASJC Scopus subject areas

  • Internal Medicine
  • Endocrinology, Diabetes and Metabolism

Fingerprint Dive into the research topics of 'Studies with (+) octanoylcarnitine in experimental diabetic ketoacidosis'. Together they form a unique fingerprint.

  • Cite this